Companies: 10,795·Total market cap: $144.5T

Biohaven Ltd.

Biohaven Ltd.

BHVNNYSEHealthcare● Active

$11.12

+$0.32(+2.96%)

Market Cap$1.2B

P/E Ratio—

52W High$18.566

52W Low$7.48

Avg Volume2.3M

Open$10.97

Beta3.31

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Biohaven Ltd.（BHVN）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BHVN · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-5.67Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding107.6MShares outstanding history

Next EarningsAug 10, 2026Est.Earnings history

探索 Biohaven Ltd. 数据

分析师预测$18 · Buy

股息不分红

盈利EPS $-6.86+26.08%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$738.8M▲ +12.71% YoY

202320242025

FY 2025EPS$-6.86▲ +26.08% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$647.7MEPS: $-5.67View income statement →

分析师评级与目标价

Buy25 位分析师

Strong Buy

0

Buy

18

Hold

7

Sell

0

Strong Sell

0

12-Month Price Target

$10.00Low

$11.12Current

$17.60Avg Target上涨空间 58.27%

$23.00High

合计: 25 · 买入占比: 72.0%

根据过去 3 个月内 25 位华尔街分析师，BHVN 共识评级为 Buy，12 个月平均目标价 $17.60 （较现价 $11.12 上涨空间 58.27%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$11.12+2.96%$1.2B #2

AbCellera Biologics Inc.

$5.42-3.56%$1.7B #3

Celldex Therapeutics, Inc.

$28.56-0.21%$1.9B #4

Immunocore Holdings plc

$27.79-1.77%$1.4B #5

$18.61+0.16%$1.8B #6

Intellia Therapeutics, Inc.

$13.49-0.37%$1.5B

股票表现

1D+3.24%

1W+11.95%

1M+13.08%

3M+12.40%

YTD-1.24%

1Y-34.68%

5Y+52.74%

关于 Biohaven Ltd.

CEOVladimir Coric

IPO DateSep 23, 2022

Employees256

CountryUS

Websitebiohaven.com

Biohaven Ltd. operates as a biopharmaceutical firm actively engaged in clinical trials. Its primary objective is to advance innovative treatments for disorders affecting the nervous and immune systems…

Biotechnology HealthcareNYSEUS

关于股票概览与关键数据

Biohaven Ltd.（BHVN）是 Biotechnology 行业的 Healthcare 类公司，于 Sep 23, 2022 在 NYSE 上市。截至最近交易日，BHVN 股价为 $11.12，市值约为 $1.2B。过去12个月累计回报 -34.68%，年初至今回报 -1.24%。

根据 25 位华尔街分析师，Biohaven Ltd. 股票共识评级为Buy，12个月平均目标价为 $17.60。2025 财年 Biohaven Ltd. 营收 —，净利润 -$738.8M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Biohaven Ltd.（BHVN）股价为 $11.12，在 NYSE 上市，52周区间为 $7.48 – $18.57。

BHVN 最新股价BHVN quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议